dpp 4 inhibitors vs glp 1 agonist GLP-1 analogues and DPP-4 in type 2 diabetes therapy: from structural biology to clinics fig2.gif

From steatosis to cirrhosis: the role of obesity in the progression of liver disease

Contaminated vials can cause injection site infections and render expensive peptides useless

This distinction has shown to provide substantial weight reduction and improved glycemic control in adults with obesity and type 2 diabetes

Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy

For this reason, we did an inverse probability of censoring weighting sensitivity analysis, which yielded point estimates that were very similar to those of the primary analysis

Ozempic is FDA-approved to help with blood sugar management in people with diabetes, while Wegovy is approved for weight loss in people who are overweight or struggle with obesity